30 Day Trial
BARE BONES logo

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Episurf Medical Commencing Enrollment in Episealer Knee IDE Clinical Study -

Episurf Medical is set to begin patient enrollment in the U.S. Investigational Device Exemption clinical study of the EPIC-Knee Episealer® Knee. Episurf is in contract negotiations with additional U.S. sites, and will include participants in three European countries, as well. The study allows for additional sites, should the company want to increase the number in the coming weeks. The randomized, controlled 180-patient IDE study is the first step for Episurf to gain U.S. premarket approval for the device. The study will evaluate Episealer vs. microfracture in the treatment of focal femoral knee chondral or osteochondral lesions. (Episurf Medical, 6/26/19)